MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Thermo Fisher Scientific EBITDA per Share 2011-2026 | TMO
Annual EBITDA per Share Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.3 | 22.2 | 20.5 | 23.9 | 27.6 | 21.3 | 14.7 | 13.9 | 11.8 | 10.2 | 9.45 | 8.13 | 6.8 | 6.35 | 5.24 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 27.6 | 5.24 | 15 |
Quarterly EBITDA per Share Thermo Fisher Scientific
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.74 | 5.53 | 5.27 | 5.57 | 5.49 | 5.1 | - | - | 4.7 | - | 6.22 | 5.1 | 7.83 | - | 7.34 | 5.5 | 8.24 | - | 7.31 | 4.3 | 2.66 | - | 3.4 | 4.43 | 2.63 | - | 2.6 | 2.65 | 3.39 | - | 5.29 | 4.34 | 2.77 | - | 4.62 | 3.78 | 2.36 | - | 4.58 | 3.59 | 2.27 | - | 4.74 | 2.88 | 3.16 | - | 3.16 | 2.43 | 1.78 | - | 2.98 | 2.32 | 1.64 | - | 2.45 | 1.7 | 1.3 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.24 | 1.3 | 4.07 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Castle Biosciences
CSTL
|
-0.07 | $ 20.36 | -0.88 % | $ 590 M |  USA |
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 17.11 | -1.55 % | $ 517 M | USA |
 |
Guardant Health
GH
|
-3.17 | $ 118.67 | 0.56 % | $ 14.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 116.26 | -0.27 % | $ 9.59 B |  Irlanda |
 |
Agilent Technologies
A
|
5.49 | $ 114.91 | 0.1 % | $ 34.9 B | USA |
 |
Illumina
ILMN
|
-3.01 | $ 144.97 | 0.1 % | $ 23.1 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 140.27 | -1.59 % | $ 6.56 B | USA |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 3.77 | 1.62 % | $ 5.01 M | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 22.03 | 2.13 % | $ 1.17 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M |  Israel |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 93.98 | -0.52 % | $ 6.34 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 1.82 | 1.11 % | $ 8.05 M | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 431.07 | 0.23 % | $ 12.4 B | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 101.7 | 1.02 % | $ 22.7 B |  Schweiz |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
Personalis
PSNL
|
-0.87 | $ 8.64 | 4.73 % | $ 771 M | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 159.55 | 0.39 % | $ 7.91 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 9.25 | 1.54 % | $ 1.18 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 19.03 | -0.05 % | $ 426 M | USA |
 |
Natera
NTRA
|
-5.33 | $ 205.51 | 0.89 % | $ 20.2 B | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 3.84 | -1.79 % | $ 356 M | USA |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-1.86 | $ 61.01 | 3.7 % | $ 3.65 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.69 | $ 27.1 | -0.15 % | $ 25.7 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.37 | 3.33 % | $ 266 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
0.22 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.4 | -1.64 % | $ 5.51 M | USA |
 |
Waters Corporation
WAT
|
6.02 | $ 340.15 | -0.2 % | $ 20.3 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 259.15 | 1.4 % | $ 21.6 B | USA |
 |
Exagen
XGN
|
-0.56 | $ 4.3 | 0.7 % | $ 92.7 M | USA |
 |
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.61 | -2.43 % | $ 219 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.16 | 3.44 % | $ 1.99 B | USA |